Still Life

Lady Lions Alex Bentley, left, and Zhaque Gray celebrate their Big Ten championship after beating Ohio State 84-66 on Monday, Feb. 20, at the Bryce Jordan Center on Penn State's University Park campus. The Lady Lions clinched their first conference regular season title since 2004.

Lady Lions win Big Ten championship

THON 2012 shattered last year's total, raising $10,686,924.83 for the Four Diamonds Fund.

THON 2012 breaks $10 million

THON child Megan Eslinger, 4, chases bubbles blown by dancer Elizabeth Ferrari on Saturday afternoon, Feb. 18, during THON at the Bryce Jordan Center on Penn State's University Park campus. The 46-hour no-sitting, no-sleeping event raises millions of dollars each year for the Four Diamonds Fund.

THON 2012 going strong

Owen Divers and Quinn Allen started off strong for THON 2012 on Friday, Feb. 17.

THON 2012 under way

Mike Rybar made final adjustments to the Penn State Institute of Electrical and Electronic Engineering teams Goldberg machine prior to the 2012 Rube Goldberg competition held on Feb. 11 at Penn State's Nittany Lion Inn. Rybar and his team created a musically themed machine that needed to complete a simple task (inflate a balloon) in twenty or more elaborate steps. The annual competition is named for cartoonist Rube Goldberg who created famous artwork depicting overly complicated machines doing everyday tasks.

Rube Goldberg Competition: Feb. 11, 2012

Featured Video

We ... are Penn State (December 19, 2011)

We ... are Penn State (December 19, 2011)

Penn State's creamery, from the cow to the cone

Penn State's creamery, from the cow to the cone

Researchers use balloons to unlock mysteries posed by dying stars

Researchers use balloons to unlock mysteries posed by dying stars

Everyday virus proves potent against cancer cells.

Everyday virus proves potent against cancer cells.

Possible cure for leukemia found by Penn State researchers

The compound shown above is D12-PGJ2, which closely resembles delta-12-protaglandin J3, or D12-PGJ3, a compound that targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice during experiments conducted by Penn State researchers. According to the American Cancer Society, about 5,150 new cases of CML are reported annually and approximately 270 people die from the disease each year.

The compound shown above is D12-PGJ2, which closely resembles delta-12-protaglandin J3, or D12-PGJ3, a compound that targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice during experiments conducted by Penn State researchers. According to the American Cancer Society, about 5,150 new cases of CML are reported annually and approximately 270 people die from the disease each year.

Credit: Sandeep Prabhu December 15, 2011

Penn State researchers Sandeep Prahbu (right) and Robert Paulson (left) sketch out a delta-12-protaglandin J3, or D12-PGJ3. The compound, derived from fish oil, targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice.

Penn State researchers Sandeep Prahbu (right) and Robert Paulson (left) sketch out a delta-12-protaglandin J3, or D12-PGJ3. The compound, derived from fish oil, targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice.

Credit: Patrick Mansell, Penn State December 15, 2011

Penn State researchers said that delta-12-protaglandin J3, or D12-PGJ3, is a promising treatment for the treatment of leukemia. The compound, which is made from fish oil, can target and kill leukemia stem cells. The team plans to conduct human trials on the compound soon.

Penn State researchers said that delta-12-protaglandin J3, or D12-PGJ3, is a promising treatment for the treatment of leukemia. The compound, which is made from fish oil, can target and kill leukemia stem cells. The team plans to conduct human trials on the compound soon.

Credit: Patrick Mansell, Penn State December 15, 2011

Sandeep Prahbu, associate professor of immunology and molecular toxicology in the department of veterinary and medical sciences, Penn State, specializes in the study of the health benefits of fish oil. He co-directed a study that discovered a treatment that uses a compound produced from fish oil to kill stem cells in chronic myelogenous leukemia, or CML, in mice. The team plans to conduct human trials soon. Credit: Patrick Mansell

Sandeep Prahbu, associate professor of immunology and molecular toxicology in the department of veterinary and medical sciences, Penn State, specializes in the study of the health benefits of fish oil. He co-directed a study that discovered a treatment that uses a compound produced from fish oil to kill stem cells in chronic myelogenous leukemia, or CML, in mice. The team plans to conduct human trials soon. Credit: Patrick Mansell

Credit: Patrick Mansell December 15, 2011

Robert Paulson, associate professor of veterinary and biomedical sciences, Penn State, injects a sample into the mass spectrometer in the lab at the Henning Building on Penn State's University Park campus. The device was used in research to find a treatment for leukemia. 

Credit: Patrick Mansell, Penn State

Robert Paulson, associate professor of veterinary and biomedical sciences, Penn State, injects a sample into the mass spectrometer in the lab at the Henning Building on Penn State's University Park campus. The device was used in research to find a treatment for leukemia. Credit: Patrick Mansell, Penn State

Credit: Patrick Mansell, Penn State December 15, 2011

Robert Paulson, associate professor of veterinary and biomedical sciences at Penn State, examines a sample in a lab on the University Park campus. Paulson, who specializes in the study of leukemia, co-directed the research on using a compound made from fish oil as a way to treat leukemia.

Robert Paulson, associate professor of veterinary and biomedical sciences at Penn State, examines a sample in a lab on the University Park campus. Paulson, who specializes in the study of leukemia, co-directed the research on using a compound made from fish oil as a way to treat leukemia.

Credit: Patrick Mansell, Penn State December 15, 2011

Leukemia stem cells are unharmed by current leukemia treatments. A treatment created by a team Penn State College of Agricultural Sciences researchers was able to kill the stem cells of chronic myelogenous leukemia, or CML, in mice. CML is a type of leukemia that claims the lives of hundreds of Americans each year.

Leukemia stem cells are unharmed by current leukemia treatments. A treatment created by a team Penn State College of Agricultural Sciences researchers was able to kill the stem cells of chronic myelogenous leukemia, or CML, in mice. CML is a type of leukemia that claims the lives of hundreds of Americans each year.

Credit: Patrick Mansell, Penn State December 15, 2011

A sample is placed in a mass spectrometer in the lab at the Henning Building on Penn State's University Park campus. The team uses the device to detect and analyze compounds in their research on possible treatments for leukemia.

A sample is placed in a mass spectrometer in the lab at the Henning Building on Penn State's University Park campus. The team uses the device to detect and analyze compounds in their research on possible treatments for leukemia.

Credit: Patrick Mansell, Penn State December 15, 2011

Penn State researchers initially tested a compound produced from fish oil on a type of leukemia found in mice called the Friend Virus. This slide shows a Friend Virus Leukemia Stem Cell. Learning how to target and kill leukemia stem cells is critical to finding a cure for leukemia.

Penn State researchers initially tested a compound produced from fish oil on a type of leukemia found in mice called the Friend Virus. This slide shows a Friend Virus Leukemia Stem Cell. Learning how to target and kill leukemia stem cells is critical to finding a cure for leukemia.

Credit: Robert Paulson December 16, 2011